|
Sep 27
|
Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41%
|
|
Sep 27
|
Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels
|
|
Sep 27
|
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
|
|
Sep 26
|
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
|
|
Sep 26
|
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
|
|
Sep 26
|
PreAnalytiX introduces urine liquid biopsy solution
|
|
Sep 25
|
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
|
|
Sep 24
|
QGEN Stock Might Rise on Partnership With Bode for GEDmatch PRO
|
|
Sep 23
|
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
|
|
Sep 23
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
|
Sep 5
|
QIAGEN Stock Likely to Gain on Collaboration for APOE Genotyping
|
|
Sep 5
|
Qiagen and Lilly team up for Alzheimer’s genotype test
|
|
Sep 4
|
QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease
|
|
Sep 3
|
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
|
|
Sep 3
|
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
|
|
Sep 3
|
QIAGEN N.V. launches non-US offering of net share settled convertible bonds
|
|
Aug 30
|
Why Is Qiagen (QGEN) Down 0.3% Since Last Earnings Report?
|
|
Aug 30
|
QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases
|
|
Jul 25
|
Ultragenyx (RARE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
|
|
Jul 24
|
Qiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?
|